Inspiration Healthcare Group plc
(“Inspiration Healthcare”, the “Company” or the “Group”)
Notice of Results
Investor & analyst briefings
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces it will issue unaudited interim results for the six months ended 31 July 2026 on 27 October 2026.
Analyst briefing
A briefing open to equity research analysts will take place on 27 October 2026 at 09:30am GMT. To register and for more details please contact Walbrook PR on inspirationhealthcare@walbrookpr.com.
Investor presentation
Raffi Stepanian CEO, and Alan Olby CFO, will provide a live presentation relating to the results via the Investor Meet Company platform on 27 October 2026 at 11:00am GMT.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free and add to meet Inspiration Healthcare.
To register for the presentation, please do so here.
Investors who already follow Inspiration Healthcare on the Investor Meet Company platform will automatically be invited.
For further information, please contact:
|
Inspiration Healthcare Group plc |
Tel: +44 (0)20 7496 3000 |
||||
|
Raffi Stepanian, Chief Executive Officer |
|
||||
|
Alan Olby, Chief Financial Officer |
|
||||
|
|
|
||||
|
Singer Capital Markets (Nominated Adviser & Broker) |
Tel: +44 (0)20 7496 3000 |
||||
|
Alex Bond Graham Hertrich |
|
||||
|
Patrick Weaver |
|
||||
|
|
|
||||
|
Cavendish Capital Markets (Joint Broker) |
Tel: + 44 (0)20 7220 0500 |
||||
|
Giles Balleny / Joe Smith |
|
||||
|
Nigel Birks |
|
||||
|
Harriet Ward |
|
||||
|
|
|
||||
|
Walbrook PR Ltd (Media & IR) |
Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com |
||||
|
Anna Dunphy |
Mob: +44 (0) 7876 741 001 |
||||
|
Rachel Broad |
Mob: +44 (0) 7747 515 393 |
||||

About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.
The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.
The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy. In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.
The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and in the USA from its facility in Melbourne, Florida.
Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com